omniture
拓维创新生物科技(香港)有限公司 Tavotek Biotherapeutics (Hong Kong) Limited

Latest News

Tavotek Biotherapeutics Announces Completion of Round A1 and A2 Financing with over $20 Million Dollars

LOWER GWYNEDD, Pennsylvania, March 22, 2021 /PRNewswire/ -- Tavotek Biotherapeutics announces it ha...

2021-03-22 19:00 1167

Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab's DuoBody® Platform against a Pair of Disease Relevant Targets

AMBLER, Pa., May 25, 2020 /PRNewswire/ -- Tavotek Biotherapeutics, a biotech company which develops...

2020-05-25 22:00 1411